Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
non-small cell lung cancer
Biotech
GSK inks model deal in $50M bet on Noetik's cancer AI platform
GSK has committed $50 million in upfront capital and near-term milestones to secure a license to two cancer research foundation models from Noetik.
Nick Paul Taylor
Jan 8, 2026 10:30am
Ose narrows focus to conserve cash at expense of wider pipeline
Dec 9, 2025 9:41am
BioNTech's CTLA-4 drug improves survival in phase 3 cancer trial
Dec 8, 2025 7:47am
Nuvalent races to FDA to challenge Pfizer for lung cancer market
Nov 17, 2025 7:45am
Fierce Pharma
Merck grows more ambitious about 'workhorse' TROP2 ADC
Oct 20, 2025 4:00pm
Fierce Pharma
Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC
Oct 19, 2025 10:45am